Ohio Man Beats Esophageal Cancer With New Treatment

John Marmer spent months unable to eat without getting sick, never realizing food wasn't reaching his stomach. The 64-year-old from Cincinnati watched his breathing worsen and his weight drop until he finally sought help in June 2025.

Doctors diagnosed him with esophageal cancer and offered him something new. They suggested combining traditional chemotherapy with immunotherapy, a treatment that trains the body's immune system to fight cancer cells alongside the medication.

Marmer became the first patient at University of Cincinnati Health to receive this dual approach both before and after surgery. Dr. Robert Van Haren, who treated Marmer, explained that the immunotherapy helps the body's natural defenses kill cancer while chemo shrinks the tumor.

The results showed up fast. After starting treatment, Marmer could finally eat mashed potatoes for the first time in months. "After being confined to a chair, this is great," he said during a recent walk, something he couldn't manage a year ago.

The stakes were high. The National Cancer Institute reports that fewer than half of esophageal cancer patients survive five years after diagnosis. But the new combination treatment is changing those odds, according to Van Haren's research.

Why This Inspires

Marmer's story shows how medical innovation is turning dire diagnoses into survivable conditions. What makes this treatment revolutionary isn't just that it works better, it's that it enlists the patient's own immune system as a partner in healing. Van Haren hopes this protocol will become standard care, giving thousands of future patients the same chance Marmer received.

The experience transformed how Marmer sees his days. "Count every day as a blessing," he said. "You really don't think about it until you're there."

Now back on his feet and enjoying food again, Marmer is looking forward to his golden years with gratitude and a perspective he never had before his diagnosis.